These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 12973117)
21. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells. Gorczynski L; Chen Z; Hu J; Kai Y; Lei J; Ramakrishna V; Gorczynski RM J Immunol; 1999 Jan; 162(2):774-81. PubMed ID: 9916698 [TBL] [Abstract][Full Text] [Related]
22. Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease. Saito K; Yagita H; Hashimoto H; Okumura K; Azuma M Eur J Immunol; 1996 Dec; 26(12):3098-106. PubMed ID: 8977310 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86. Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826 [TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma. Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203 [TBL] [Abstract][Full Text] [Related]
25. Effects of RNA interference on CD80 and CD86 expression in bone marrow-derived murine dendritic cells. Gu X; Xiang J; Yao Y; Chen Z Scand J Immunol; 2006 Dec; 64(6):588-94. PubMed ID: 17083614 [TBL] [Abstract][Full Text] [Related]
26. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Jun HX; Jun CY; Yu ZX Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404 [TBL] [Abstract][Full Text] [Related]
27. Dendritic cells conditioned with NK026680 prolong cardiac allograft survival in mice. Shibasaki S; Yamashita K; Yanagawa Y; Goto R; Wakayama K; Hirokata G; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Todo S Transplantation; 2012 Jun; 93(12):1229-37. PubMed ID: 22643332 [TBL] [Abstract][Full Text] [Related]
28. Ketamine inhibits maturation of bone marrow-derived dendritic cells and priming of the Th1-type immune response. Ohta N; Ohashi Y; Fujino Y Anesth Analg; 2009 Sep; 109(3):793-800. PubMed ID: 19690248 [TBL] [Abstract][Full Text] [Related]
29. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice. Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220 [No Abstract] [Full Text] [Related]
30. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells. Delgado M; Reduta A; Sharma V; Ganea D J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654 [TBL] [Abstract][Full Text] [Related]
31. Administration of antisense oligodeoxyribonucleotides against mRNA of CD80 or CD86 prolongs survival of cardiac allografts by inhibition of CTL activity. Qian S; Wang Z; Li W; Chen Z; Zhang H; Vickers T; Fung JJ; Lu L Transplant Proc; 2001; 33(1-2):551. PubMed ID: 11266953 [No Abstract] [Full Text] [Related]
32. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity. Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908 [TBL] [Abstract][Full Text] [Related]
34. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo. Cai Y; Zhou PJ; Tang XD Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291 [TBL] [Abstract][Full Text] [Related]
35. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
36. [Impact of novel negative immunoregulatory dendritic cells on regulatory T cells in cardiac allograft recipient rats]. Zheng DH; Shi BY; Zou YP; Cai M; Qian YY; Hong BF; Dou LP; Li L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):13-7. PubMed ID: 20056079 [TBL] [Abstract][Full Text] [Related]
37. Administration of dendritic cells modified by RNA interference prolongs cardiac allograft survival. Xiang J; Gu X; Zhou Y; Gong X; Qian S; Chen Z Microsurgery; 2007; 27(4):320-3. PubMed ID: 17477425 [TBL] [Abstract][Full Text] [Related]
38. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463 [TBL] [Abstract][Full Text] [Related]
39. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. Feili-Hariri M; Falkner DH; Morel PA J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574 [TBL] [Abstract][Full Text] [Related]
40. Mycophenolic acid upregulates B7-DC expression on dendritic cells, which is associated with impaired allostimulatory capacity of dendritic cells. Geng L; Jiang G; Xie H; Fang Y; Dong S; Chen Y; Shen M; Zheng S Transplant Proc; 2006 Jun; 38(5):1622-4. PubMed ID: 16797370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]